ResearcherUniversity of JordanActive in the last 2 years

Qamar Abuhassan

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0009-0003-6898-8852; OpenAlex author ID A5120466429. Sources: OpenAlex.

Their work

Papers: 2
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 3

Papers, trials and grants by year

2026: 2 papers

Papers 2

Convergence of multiplexed immunosensors, nanotechnology, and AI for early pancreatic cancer diagnosis. Co-author DOI 10.1016/j.cca.2026.121005 ↗
Emerging nanoparticle approaches for early detection and therapeutic targeting of pancreatic cancer. Co-author DOI 10.1016/j.cca.2026.121102 ↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Mohamed Adil Jaber · 1 shared paper, 2026 · strength 0.33
- Paper Emerging nanoparticle approaches for early detection and therapeutic targeting of pancreatic cancer. DOI 10.1016/j.cca.2026.121102 ↗
Vimal Arora · 1 shared paper, 2026 · strength 0.26
- Paper Convergence of multiplexed immunosensors, nanotechnology, and AI for early pancreatic cancer diagnosis. DOI 10.1016/j.cca.2026.121005 ↗
Mohaned Adil · 1 shared paper, 2026 · strength 0.26
- Paper Convergence of multiplexed immunosensors, nanotechnology, and AI for early pancreatic cancer diagnosis. DOI 10.1016/j.cca.2026.121005 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.